Last reviewed · How we verify
Intra-articular injection of ADMSC — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Intra-articular injection of ADMSC (Intra-articular injection of ADMSC) — Medical University of Warsaw.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intra-articular injection of ADMSC TARGET | Intra-articular injection of ADMSC | Medical University of Warsaw | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intra-articular injection of ADMSC CI watch — RSS
- Intra-articular injection of ADMSC CI watch — Atom
- Intra-articular injection of ADMSC CI watch — JSON
- Intra-articular injection of ADMSC alone — RSS
Cite this brief
Drug Landscape (2026). Intra-articular injection of ADMSC — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-articular-injection-of-admsc. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab